TY - JOUR
T1 - Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion
AU - Del Papa, Nicoletta
AU - Guidali, Luisa
AU - Sironi, Marina
AU - Shoenfeld, Yehuda
AU - Mantovani, Alberto
AU - Tincani, Angela
AU - Balestrieri, Genesio
AU - Radice, Antonella
AU - Sinico, R. Alberto
AU - Meroni, Pier Luigi
PY - 1996/5
Y1 - 1996/5
N2 - Objective. To elucidate the role of antiendothelial cell antibodies (AECA) in vascular inflammation in patients with Wegener's granulomatosis (WG). Methods. IgG fractions from 3 AECA-positive WG patients, IgG from 3 AECA- negative WG patients, and IgG from healthy donors were tested for their ability to: a) bind to endothelial cells and to display complement-dependent or antibody-dependent cellular cytotoxicity, b) modulate cell membrane expression of adhesion molecules, as evaluated by cytofluorometry and by immunoenzymatic assay, and c) induce the secretion of interleukin-1β (IL- 1β), IL-6, IL-8, and monocyte chemotactic protein 1 (MCP-1). Results. We found that AECA IgG from WG patients do not display any significant cytotoxicity but are able to up-regulate the expression of E-selectin, intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 and to induce the secretion of IL-1β, IL-6, IL-8, and MCP-1. Conclusion. AECA in patients with WG could play a potential pathogenetic role by activating endothelial cells, and thus facilitating leukocyte recruitment and adhesion to endothelial surfaces, rather than by displaying a cytotoxic activity.
AB - Objective. To elucidate the role of antiendothelial cell antibodies (AECA) in vascular inflammation in patients with Wegener's granulomatosis (WG). Methods. IgG fractions from 3 AECA-positive WG patients, IgG from 3 AECA- negative WG patients, and IgG from healthy donors were tested for their ability to: a) bind to endothelial cells and to display complement-dependent or antibody-dependent cellular cytotoxicity, b) modulate cell membrane expression of adhesion molecules, as evaluated by cytofluorometry and by immunoenzymatic assay, and c) induce the secretion of interleukin-1β (IL- 1β), IL-6, IL-8, and monocyte chemotactic protein 1 (MCP-1). Results. We found that AECA IgG from WG patients do not display any significant cytotoxicity but are able to up-regulate the expression of E-selectin, intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 and to induce the secretion of IL-1β, IL-6, IL-8, and MCP-1. Conclusion. AECA in patients with WG could play a potential pathogenetic role by activating endothelial cells, and thus facilitating leukocyte recruitment and adhesion to endothelial surfaces, rather than by displaying a cytotoxic activity.
UR - http://www.scopus.com/inward/record.url?scp=15844423167&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=15844423167&partnerID=8YFLogxK
U2 - 10.1002/art.1780390507
DO - 10.1002/art.1780390507
M3 - Article
C2 - 8639172
AN - SCOPUS:15844423167
VL - 39
SP - 758
EP - 766
JO - Arthritis care and research : the official journal of the Arthritis Health Professions Association
JF - Arthritis care and research : the official journal of the Arthritis Health Professions Association
SN - 0893-7524
IS - 5
ER -